Longitudinal Associations of Mental Disorders With Physical Diseases and Mortality Among 2.3 Million New Zealand Citizens.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
04 01 2021
Historique:
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 16 3 2021
Statut: epublish

Résumé

Excess risk of physical disease and mortality has been observed among individuals with psychiatric conditions, suggesting that ameliorating mental disorders might also be associated with ameliorating the later onset of physical disability and early mortality. However, the temporal association between mental disorders and physical diseases remains unclear, as many studies have relied on retrospective recall, used cross-sectional designs or prospective designs with limited follow-up periods, or given inadequate consideration to preexisting physical illnesses. To examine whether mental disorders are associated with subsequent physical diseases and mortality across 3 decades of observation. This population-based cohort study used data from the New Zealand Integrated Data Infrastructure, a collection of nationwide administrative data sources linked at the individual level, to identify mental disorders, physical diseases, and deaths recorded between July 1, 1988, and June 30, 2018, in the population of New Zealand. All individuals born in New Zealand between January 1, 1928, and December 31, 1978, who resided in the country at any time during the 30-year observation period were included in the analysis. Data were analyzed from July 2019 to November 2020. Nationwide administrative records of mental disorder diagnoses made in public hospitals. Chronic physical disease diagnoses made in public hospitals, deaths, and health care use. The study population comprised 2 349 897 individuals (1 191 981 men [50.7%]; age range at baseline, 10-60 years). Individuals with a mental disorder developed subsequent physical diseases at younger ages (hazard ratio [HR], 2.33; 95% CI, 2.30-2.36) and died at younger ages (HR, 3.80; 95% CI, 3.72-3.89) than those without a mental disorder. These associations remained across sex and age and after accounting for preexisting physical diseases. Associations were observed across different types of mental disorders and self-harm behavior (relative risks, 1.78-2.43; P < .001 for all comparisons). Mental disorders were associated with the onset of physical diseases and the accumulation of physical disease diagnoses (incidence rate ratio [IRR], 2.00; 95% CI, 1.98-2.03), a higher number of hospitalizations (IRR, 2.43; 95% CI, 2.39-2.48), longer hospital stays for treatment (IRR, 2.70; 95% CI, 2.62-2.79), and higher associated health care costs (b = 0.115; 95% CI, 0.112-0.118). In this study, mental disorders were likely to begin and peak in young adulthood, and they antedated physical diseases and early mortality in the population. These findings suggest that ameliorating mental disorders may have implications for improving the length and quality of life and for reducing the health care costs associated with physical diseases.

Identifiants

pubmed: 33439264
pii: 2774902
doi: 10.1001/jamanetworkopen.2020.33448
pmc: PMC7807295
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2033448

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD065563
Pays : United States
Organisme : NICHD NIH HHS
ID : R03 HD050374
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG028716
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG034424
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG032282
Pays : United States
Organisme : Medical Research Council
ID : MR/P005918/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005918
Pays : United Kingdom

Références

JAMA Netw Open. 2020 Apr 1;3(4):e203221
pubmed: 32315069
Schizophr Res. 2008 Apr;101(1-3):273-86
pubmed: 18258416
Lancet Psychiatry. 2018 Mar;5(3):237-286
pubmed: 29482764
JAMA Psychiatry. 2020 Aug 1;77(8):806-813
pubmed: 32267482
Br J Psychiatry. 2011 Dec;199(6):453-8
pubmed: 21593516
JAMA Netw Open. 2019 Nov 1;2(11):e1915245
pubmed: 31722030
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
Lancet. 2019 Nov 16;394(10211):1827-1835
pubmed: 31668728
Health Place. 2019 Mar;56:70-79
pubmed: 30710836
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
N Engl J Med. 2020 Apr 30;382(18):1721-1731
pubmed: 32348643
JAMA Psychiatry. 2019 May 1;76(5):461-462
pubmed: 30916735
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
Int J Bipolar Disord. 2019 Mar 1;7(1):6
pubmed: 30820700
J Clin Psychiatry. 2007;68 Suppl 1:20-7
pubmed: 17286524
JAMA Neurol. 2020 Jun 1;77(6):700-709
pubmed: 32150226
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Front Psychiatry. 2018 Sep 28;9:463
pubmed: 30323773
Arch Gen Psychiatry. 2011 Aug;68(8):838-44
pubmed: 21810647
N Z Med J. 2014 May 23;127(1394):31-41
pubmed: 24929569
Int J Epidemiol. 2019 Jun 1;48(3):677-677e
pubmed: 30793742
Lancet. 2012 Mar 24;379(9821):1112-9
pubmed: 22353263
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
JAMA Psychiatry. 2016 Feb;73(2):150-8
pubmed: 26719969
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783
JAMA Netw Open. 2020 Jun 1;3(6):e206646
pubmed: 32492163
Fam Syst Health. 2010 Jun;28(2):83-90
pubmed: 20695668
Clin Psychol Rev. 2019 Aug;72:101751
pubmed: 31271848
Lancet Public Health. 2020 Mar;5(3):e140-e149
pubmed: 32007134
PLoS One. 2013;8(1):e55176
pubmed: 23372832
JAMA Psychiatry. 2020 Jun 1;77(6):648-650
pubmed: 32267492
Lancet Psychiatry. 2017 Dec;4(12):937-945
pubmed: 29122573

Auteurs

Leah S Richmond-Rakerd (LS)

Department of Psychology, University of Michigan, Ann Arbor.

Stephanie D'Souza (S)

Centre of Methods and Policy Application in the Social Sciences, University of Auckland, Auckland, New Zealand.

Barry J Milne (BJ)

Centre of Methods and Policy Application in the Social Sciences, University of Auckland, Auckland, New Zealand.

Avshalom Caspi (A)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.
Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England.
Promenta Center, University of Oslo, Oslo, Norway.

Terrie E Moffitt (TE)

Department of Psychology and Neuroscience, Duke University, Durham, North Carolina.
Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.
Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England.
Promenta Center, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH